日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FRMPD4, a causal gene for intellectual disability and epilepsy, is associated with X-linked non-syndromic hearing loss

FRMPD4是导致智力障碍和癫痫的致病基因,也与X连锁非综合征性听力损失有关。

Liedtke, Daniel; Rak, Kristen; Schrode, Katrina M; Hehlert, Philip; Chamanrou, Niloofar; Bengl, Daniel; Katana, Radoslaw; Heydaran, Soganad; Doll, Julia; Han, Mei; Nanda, Indrajit; Senthilan, Pingkalai R; Jürgens, Lukas; Bieniussa, Linda; Voelker, Johannes; Neuner, Cordula; Hofrichter, Michaela Ah; Schröder, Jörg; Schellens, Renske T W; de Vrieze, Erik; van Wijk, Erwin; Zechner, Ulrich; Herms, Stefan; Hoffmann, Per; Müller, Tobias; Dittrich, Marcus; Bartsch, Oliver; Krawitz, Peter M; Klopocki, Eva; Shehata-Dieler, Wafaa; Maroofian, Reza; Wang, Tao; Worley, Paul F; Göpfert, Martin C; Galehdari, Hamid; Lauer, Amanda M; Haaf, Thomas; Vona, Barbara

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors

索拉非尼联合吉西他滨和卡铂治疗晚期实体瘤患者的I期研究

Voogd, Daphne W M; Lucassen, Merel J J; van der Noll, Ruud; Zielhuis, Sybrand W J; Boss, David; Beijnen, Jos H; Rosing, Hilde; Tibben, Matthijs; Huitema, Alwin D R; Schellens, Jan H M; Steeghs, Neeltje

Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type

DPYD野生型基因突变导致老年癌症患者出现严重的氟尿嘧啶毒性

Brokaar, Edwin; Knikman, Jonathan; Visser, Loes; van den Bos, Frederiek; Henricks, Linda; Lunenburg, Carin; de Man, Femke; Gelderblom, Hans; Schellens, Jan; Mathijssen, Ron; Guchelaar, Henk-Jan; Portielje, Johanneke; Cats, Annemieke; Postmus, Wout; de Glas, Nienke

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD

在DPYD公司内外发现与严重氟嘧啶类药物相关毒性相关的新型种系遗传变异

Knikman, Jonathan E; Zhai, Qinglian; Lunenburg, Carin A T C; Henricks, Linda M; Böhringer, Stefan; van der Lee, Maaike; de Man, Femke M; Offer, Steven M; Shrestha, Shikshya; Creemers, Geert-Jan; Baars, Arnold; Dezentjé, Vincent O; Imholz, Alexander L T; Jeurissen, Frank J F; Portielje, Johanna E A; Jansen, Rob L H; Hamberg, Paul; Droogendijk, Helga J; Koopman, Miriam; Nieboer, Peter; van de Poel, Marlène H W; Mandigers, Caroline M P W; van Schaik, Ron H N; Gelderblom, Hans; Mathijssen, Ron H J; Schellens, Jan H M; Cats, Annemieke; Guchelaar, Henk-Jan; Swen, Jesse J

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis

二氢嘧啶脱氢酶基因变异预测4-5级氟嘧啶类药物引起的毒性:FUSAFE个体患者数据荟萃分析

Le Teuff, Gwénaël; Cozic, Nathalie; Boyer, Jean-Christophe; Boige, Valérie; Diasio, Robert B; Taieb, Julien; Meulendijks, Didier; Palles, Claire; Schwab, Matthias; Deenen, Maarten; Largiadèr, Carlo R; Marinaki, Anthony; Jennings, Barbara A; Wettergren, Yvonne; Di Paolo, Antonello; Gross, Eva; Budai, Barna; Ackland, Stephen P; van Kuilenburg, André B P; McLeod, Howard L; Milano, Gérard; Thomas, Fabienne; Loriot, Marie-Anne; Kerr, David; Schellens, Jan H M; Laurent-Puig, Pierre; Shi, Qian; Pignon, Jean-Pierre; Etienne-Grimaldi, Marie-Christine

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

达拉非尼联合曲美替尼治疗 BRAFV600E 突变的罕见癌症:2 期 ROAR 试验

Subbiah, Vivek; Kreitman, Robert J; Wainberg, Zev A; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y; Dietrich, Sascha; de Jonge, Maja J A; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C; de Vos, Filip Y F L; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H M; Zielinski, Christoph C; Redhu, Suman; Boran, Aislyn; Passos, Vanessa Q; Ilankumaran, Palanichamy; Bang, Yung-Jue

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

首次人体 I 期研究,评估 OX40 激动剂 GSK3174998 与或不与帕博利珠单抗联合治疗特定晚期实体瘤患者的疗效 (ENGAGE-1)

Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Rahma, Osama; Paul, Elaine M; Ahlers, Christoph M; Zhou, Helen; Struemper, Herbert; Gorman, Shelby A; Watmuff, Maura; Yablonski, Kaitlin M; Yanamandra, Niranjan; Chisamore, Michael J; Schmidt, Emmett V; Hoos, Axel; Marabelle, Aurelien; Weber, Jeffrey S; Heymach, John V

A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa

以蛋白质结构域为导向的方法扩大 USH2A 相关视网膜色素变性的外显子跳跃治疗机会

Renske T W Schellens, Sanne Broekman, Theo Peters, Pam Graave, Lucija Malinar, Hanka Venselaar, Hannie Kremer, Erik De Vrieze, Erwin Van Wijk

Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort

随着时间的推移,循环中去磷酸化未羧化基质Gla蛋白水平升高与生存率降低相关:前瞻性马斯特里赫特重症监护COVID队列研究

Mulder, Mark M G; Schellens, Joep; Sels, Jan-Willem E M; van Rosmalen, Frank; Hulshof, Anne-Marije; de Vries, Femke; Segers, Ruud; Mihl, Casper; van Mook, Walther N K A; Bast, Aalt; Spronk, Henri M H; Henskens, Yvonne M C; van der Horst, Iwan C C; Cate, Hugo Ten; Schurgers, Leon J; Drent, Marjolein; van Bussel, Bas C T

Automating the Identification of Feedback Quality Criteria and the CanMEDS Roles in Written Feedback Comments Using Natural Language Processing

利用自然语言处理技术自动识别书面反馈评论中的反馈质量标准和 CanMEDS 角色

Van Ostaeyen, Sofie; De Langhe, Loic; De Clercq, Orphée; Embo, Mieke; Schellens, Tammy; Valcke, Martin